271 related articles for article (PubMed ID: 33614485)
21. Glycolysis‑related lncRNA may be associated with prognosis and immune activity in grade II‑III glioma.
Yang T; Zhang R; Cui Z; Zheng B; Zhu X; Yang X; Huang Q
Oncol Lett; 2024 May; 27(5):238. PubMed ID: 38601183
[TBL] [Abstract][Full Text] [Related]
22. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
23. A Glycolysis-Based Long Non-coding RNA Signature Accurately Predicts Prognosis in Renal Carcinoma Patients.
Cao H; Tong H; Zhu J; Xie C; Qin Z; Li T; Liu X; He W
Front Genet; 2021; 12():638980. PubMed ID: 33868376
[TBL] [Abstract][Full Text] [Related]
24. Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma.
Wu F; Zhao Z; Chai R; Liu Y; Wang K; Wang Z; Li G; Huang R; Jiang H; Zhang K
Cancer Cell Int; 2018; 18():107. PubMed ID: 30069164
[TBL] [Abstract][Full Text] [Related]
25. N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients.
Tu Z; Wu L; Wang P; Hu Q; Tao C; Li K; Huang K; Zhu X
Front Cell Dev Biol; 2020; 8():642. PubMed ID: 32793593
[TBL] [Abstract][Full Text] [Related]
26. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
Front Oncol; 2020; 10():1119. PubMed ID: 32974125
[No Abstract] [Full Text] [Related]
27. Molecular Subtypes and Prognostic Signature of Pyroptosis-Related lncRNAs in Glioma Patients.
Tanzhu G; Li N; Li Z; Zhou R; Shen L
Front Oncol; 2022; 12():779168. PubMed ID: 35237509
[TBL] [Abstract][Full Text] [Related]
28. A Robust 6-lncRNA Prognostic Signature for Predicting the Prognosis of Patients With Colorectal Cancer Metastasis.
Li S; Chen S; Wang B; Zhang L; Su Y; Zhang X
Front Med (Lausanne); 2020; 7():56. PubMed ID: 32211413
[No Abstract] [Full Text] [Related]
29. Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patients.
Chen D; Dou C; Liu H; Xu B; Hu B; Kuang L; Yao J; Zhao Y; Yu S; Li Y; Wang F; Guo M
Front Oncol; 2022; 12():929233. PubMed ID: 36033536
[TBL] [Abstract][Full Text] [Related]
30. A novel signature based on necroptosis-related long non-coding RNAs for predicting prognosis of patients with glioma.
Xia P; Huang Y; Chen G
Front Oncol; 2022; 12():940220. PubMed ID: 36033510
[TBL] [Abstract][Full Text] [Related]
31. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
32. Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses.
Liu YQ; Wu F; Li JJ; Li YF; Liu X; Wang Z; Chai RC
Front Oncol; 2019; 9():1433. PubMed ID: 31921684
[No Abstract] [Full Text] [Related]
33. Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma.
Lu L; Liu LP; Zhao QQ; Gui R; Zhao QY
Front Oncol; 2021; 11():675545. PubMed ID: 34249715
[TBL] [Abstract][Full Text] [Related]
34. Long Non-coding RNA Expression Profiling Identifies a Four-Long Non-coding RNA Prognostic Signature for Isocitrate Dehydrogenase Mutant Glioma.
Chen Y; Guo Y; Chen H; Ma F
Front Neurol; 2020; 11():573264. PubMed ID: 33329315
[No Abstract] [Full Text] [Related]
35. A Prognostic Model of Bladder Cancer Based on Metabolism-Related Long Non-Coding RNAs.
Hu J; Lai C; Shen Z; Yu H; Lin J; Xie W; Su H; Kong J; Han J
Front Oncol; 2022; 12():833763. PubMed ID: 35280814
[TBL] [Abstract][Full Text] [Related]
36. Integrated Analysis of a Risk Score System Predicting Prognosis and a ceRNA Network for Differentially Expressed lncRNAs in Multiple Myeloma.
Zhou S; Fang J; Sun Y; Li H
Front Genet; 2020; 11():934. PubMed ID: 33193574
[TBL] [Abstract][Full Text] [Related]
37. An autophagy-related long non-coding RNA signature for glioma.
Luan F; Chen W; Chen M; Yan J; Chen H; Yu H; Liu T; Mo L
FEBS Open Bio; 2019 Apr; 9(4):653-667. PubMed ID: 30984540
[TBL] [Abstract][Full Text] [Related]
38. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
Ma B; Li Y; Ren Y
Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
[TBL] [Abstract][Full Text] [Related]
39. The lncRNAs MIR600HG and TSPOAP1-AS1 may potentially act as biomarkers for predicting pancreatic cancer.
Tian J; Wang Y
Transl Cancer Res; 2020 Feb; 9(2):809-817. PubMed ID: 35117426
[TBL] [Abstract][Full Text] [Related]
40. An immune-related lncRNA signature for patients with anaplastic gliomas.
Wang W; Zhao Z; Yang F; Wang H; Wu F; Liang T; Yan X; Li J; Lan Q; Wang J; Zhao J
J Neurooncol; 2018 Jan; 136(2):263-271. PubMed ID: 29170907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
